The BioCanRx network is changing the face of cancer treatment


BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.







Successful 2018 Summit for Cancer Immunotherapy


Beautiful Banff, Alberta, was the setting for the third annual scientific conference of BioCanRx – Canada’s Immunotherapy Network. The Summit for Cancer Immunotherapy (Summit4CI) gathered more than 300 leading scientists, clinicians, trainees and economists with representatives from industry, patient groups, charities and government from October 27-30, 2018.


Learn more →

Summit4CI 2018: The HQP Experience


This year, we offered training opportunities oriented toward undergrad and graduate students, postdocs and other technical, clinical and research staff involved in bringing promising cancer biotherapeutics to clinic – all Highly Qualified Personnel (HQP) in BioCanRx’s Community!


Learn more →

A Deadly Conundrum


How do you suppress the immune systems of children with leukemia who undergo a stem cell transplant to avoid rejection while activating that system to fight off relapses? Dr. Michel Duval is investigating this in his BioCanRx project.


Learn more →



Summit for Cancer Immunotherapy

Join the BioCanRx Network at the 4th annual Summit for Cancer Immunotherapy (Summit4CI) taking place in Victoria!

October 20-23, 2019

Fairmont Empress Hotel
Learning Institute Community Dissemination Report 2017

The participants of the 2017 BioCanRx-Cancer Stakeholder Alliance Learning Institute wish to share their Community Dissemination Report with the oncology patient and researcher community, BioCanRx, the Cancer Stakeholder Alliance, and the general public.

Click here for the full report
For the latest BioCanRx news and network activities:

Subscribe to our newsletter and email updates Subscribe
Follow us on Twitter
Like us on Facebook
Follow us on Instagram Follow
Subscribe to us on Youtube  Subscribe
Follow us on LinkedIn Follow